Skip to main content
BMC Complementary Medicine and Therapies logoLink to BMC Complementary Medicine and Therapies
. 2022 Jan 7;22:9. doi: 10.1186/s12906-021-03492-y

Discovery and identification of potential anti-melanogenic active constituents of Bletilla striata by zebrafish model and molecular docking

Yiyuan Luo 1, Juan Wang 1, Shuo Li 1, Yue Wu 1, Zhirui Wang 1, Shaojun Chen 1, Hongjiang Chen 1,2,
PMCID: PMC8742349  PMID: 34996448

Abstract

Background

Bletilla striata is the main medicine of many skin whitening classic formulas in traditional Chinese medicine (TCM) and is widely used in cosmetic industry recently. However, its active ingredients are still unclear and its fibrous roots are not used effectively. The aim of the present study is to discover and identify its potential anti-melanogenic active constituents by zebrafish model and molecular docking.

Methods

The antioxidant activities were evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, 2,2′-azino-bis-(3-ethylbenthiazoline-6-sulphonic acid) (ABTS) radical scavenging activity and ferric reducing antioxidant power (FRAP) assay. The anti-melanogenic activity was assessed by tyrosinase inhibitory activity in vitro and melanin inhibitory in zebrafish. The chemical profiles were performed by ultra-high-performance liquid chromatography combined with quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). Meanwhile, the potential anti-melanogenic active constituents were temporary identified by molecular docking.

Results

The 95% ethanol extract of B. striata fibrous roots (EFB) possessed the strongest DPPH, ABTS, FRAP and tyrosinase inhibitory activities, with IC50 5.94 mg/L, 11.69 mg/L, 6.92 mmol FeSO4/g, and 58.92 mg/L, respectively. In addition, EFB and 95% ethanol extract of B. striata tuber (ETB) significantly reduced the melanin synthesis of zebrafish embryos in a dose-dependent manner. 39 chemical compositions, including 24 stilbenoids were tentatively identified from EFB and ETB. Molecular docking indicated that there were 83 (including 60 stilbenoids) and 85 (including 70 stilbenoids) compounds exhibited stronger binding affinities toward tyrosinase and adenylate cyclase.

Conclusion

The present findings supported the rationale for the use of EFB and ETB as natural skin-whitening agents in pharmaceutical and cosmetic industries.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12906-021-03492-y.

Keywords: Bletilla striata, Antioxidant, Anti-melanogenic activity, UPLC-Q-TOF-MS/MS, Zebrafish, Molecular docking

Background

Bletilla striata (Thunb.) Reichb. f. is a herbaceous perennial plant widely distributed in Asia, such as China, Korea, and Japan [1]. The dried tuber of B. striata, also known as Baiji, firstly recorded in Shennong’s Classic of Materia Medica, has been widely used as a traditional Chinese medicine (TCM) for thousands of years in China. Chinese pharmacopeias states that it possesses the capability of astringency upon hemostasis and analgesis, therefore, it was widely used for the treatment of hematemesis, hemoptysis, traumatic bleeding, ulcers, swelling and chapped skin [2, 3]. Pharmacological studies demonstrated that B. striata possessed a wide spectrum of biological activities, such as wound healing [4, 5], anti-ulcer [6, 7], hemostatic [8], anti-inflammation [9], antioxidant [10], antibacterial [11], anti-influenza viral [12], and antiaging [13]. At the same time, B. striata contains various classes of chemical compositions, including polysaccharides [14], bibenzyls, phenanthrenes, anthraquinones, flavonoids, and 2-isobutylmalates [3, 15], etc.

B. striata is the main medicine of many skin whitening classic formulas in TCM [16] and it is widely used in cosmetic industry recently [17]. However, its active ingredients are still unclear and even some research results were contrary. For instance, the research results given by Chen et al. indicated that 95% ethanol extract of B. striata possessed higher tyrosinase inhibitory activity than those of its water extract with inhibition rate of 68.36% in vitro [18], while the result of Huang et al. showed that the inhibitory activity of B. striata water extract on tyrosinase was stronger than that of 95% ethanol extract with inhibition rate of 62% in vitro [19]. The research results by Lu et al. [20] and Linghu et al. [21] demonstrated that both water and 95% ethanol extract of B. striata, especially its chloroform fractionation, could inhibit B16 cell growth and induce its apoptosis in a concentration-dependent manner.

As the in vitro tests of tyrosinase inhibition and melanoma cell lines, didn’t involve the complex physiological in vivo conditions, and the absorption, metabolism, distribution and excretion of the test sample, many of the samples showed significant inhibitory activity against tyrosinase and melanoma cell lines in vitro, nevertheless, exhibited weakly effective or even ineffective in vivo [22, 23]. The glabridin showed significant tyrosinase inhibitory activity with IC50 0.43 μmol/L, which was 176 times stronger than that of kojic acid. Nevertheless, it was no inhibitory effects on the pigmentation of zebrafish in vivo [24].

Meanwhile, B. striata fibrous roots (FB) were the by-products generated during the processing of B. striata tuber (TB). Modern researches indicated that the FB contains similar compounds with TB and with higher content of phenolic [25]. In addition, the antibacterial [26], antioxidant and anti-tyrosinase activities of FB extract were stronger than those of TB extract [25]. However, the resources of FB were not effectively used and were abandoned in the farmland, which led to the waste of FB resources and environmental pollution [27].

Zebrafish (Danio rerio), a small tropical freshwater fish, is an emerging animal model for pharmacology and toxicology research in vivo, with many advantages including low cost, short life cycle, high transparency, easy to maintain, high fertility, and required fewer test samples [28, 29]. In addition, zebrafish has melanin pigments on the surface, allowing simple observation of the pigmentation process, and was widely used in the anti-melanogenic study [28, 30].

In the present study, we compared the antioxidant and tyrosinase inhibitory activities of crude polysaccharide and 95% ethanol extract of TB and FB in vitro, and anti-melanogenic activities in zebrafish model. Meanwhile, the potential anti-melanogenic active constituents were temporary identified by molecular docking. We discovered that 95% ethanol extract of TB (ETB) and FB (EFB) possesses the significantly antioxidant and anti-tyrosinase activities, and can reduce melanin synthesis of zebrafish embryos in a dose-dependent manner. Thus, ETB and EFB can be used as natural skin-whitening agents in pharmaceutical and cosmetic industries.

Methods

Chemicals and reagents

Tyrosinase, 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) and arbutin were purchased from Aladdin reagent company (Shanghai, China). 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis-(3-ethylbenthiazoline-6-sulphonic acid) (ABTS), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), and 2,4,6-tris (2-pyridyl)-s-triazine (TPTZ) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile and methanol (HPLC grade) were purchased from Tedia (Fairfield, OH, USA). Deionized water was prepared by the Milli-Q water system (18.2 MΩ, Millipore, USA).

Plant collection and extraction procedure

B. striata was collected from Quzhou YiNianTang Agriculture and Forestry Technology Co., Ltd. (Quzhou, Zhejiang, China). Voucher specimens were deposited at Herbarium of Zhejiang Pharmaceutical College (Accession no. 190615). The whole plant was divided into tubers and fibrous roots. Subsequently, they were cut into small pieces and dried by vacuum freeze-drying, respectively.

The dried and powdered samples (TB and FB) were reflux extracted with 95% ethanol for three times (1.5 h for each time). The extract was filtered using a Whatman filter paper (No.1). The filtrate was concentrated to dryness in a rotary evaporator (Hei-VAP, Heidolph, Germany) at 50 °C and was subseqently dried by a vacuum freeze dryer. The ethanol extraction of TB (ETB) and FB (EFB) yields were 5.21 and 6.53%, respectively. The dregs were used to extract the crude polysaccharide by dispersed in 80 °C water for 4 h and precipitation with ethanol [31]. The polysaccharide yields of TB (PTB) and FB (PFB) were 14.75 and 6.45%, respectively.

Chemical analysis

The chemical analysis was performed on an ultra-high-performance liquid chromatography combined with quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). The chromatographic separation was performed on a Waters Acquity UPLC™ system (Waters Corp., Milford, MA, US) with a Waters BEH Shield RP C18 column (100 × 2.1 mm, 1.7 μm) at 30 °C. The mobile phase was consisted of 0.1% formic acid in water (A) and acetonitrile (B), with a linear gradient: 0–3 min, 5–16% B; 3–8 min, 16–30% B; 8–10 min, 30–35% B; 10–15 min, 35–55% B; 15–18 min, 55–80% B; 18–19 min, 80–5% B; 19–20 min, 5% B. The flow rate was 0.3 mL/min, and the injection volume was 2 μL.

The TOF-MS/MS experiments were performed by using an AB SCEIX Triple TOF 5600 mass spectrometry (AB SCIEX, Foster City, CA, USA) equipped with an electrospray ionization (ESI). The MS detection was conducted in negative ionization method. The parameters were set as follows: source and desolvation temperature were 100 °C and 450 °C respectively; desolvation gas flow rate was 900 L/h; capillary voltage was 2 kV; cone voltage was 40 V; collision energy was 22 eV; and the full scan spectra was from 100 to 2000 Da.

Antioxidant assays

DPPH radical scavenging activity

The DPPH radical scavenging activity was determined in accordance with Ali et al. with slightly modifications [32]. Briefly, 50 μL test sample solution was mixed with 150 μL DPPH ethanol solution (0.2 mM) in 96-well plates and was kept in the dark for 30 min. The absorbance of the mixture at 517 nm (A1) was assessed by microplate spectrophotometer (Thermo Fisher Scientific, America). The blank solution without test sample mixed with DPPH ethanol solution was set as the positive group (A0). The blank solution without DPPH mixed with test sample solution was set as the blank group (A2). All experiments were executed in triplicate. The DPPH radical scavenging rate was calculated using the following formula:

DPPH radical scavenging rate (%) = [A0-(A1-A2)]/A0 × 100%.

ABTS radical scavenging activity

The ABTS radical scavenging capacity was measured using the method described by Ali et al. [32]. Briefly, 7 mM ABST aqueous solution was mixed with 2.45 mM potassium persulfate at a ratio of 1:1 (v/v), and incubating at room temperature in the dark for 16 h to obtain the ABST+ stock solution. The stock solution was diluted with phosphate buffered saline (PBS) to adjust the absorbance of (0.72 ± 0.2) at 734 nm. 20 μL test samples at different concentrations were mixed thoroughly with 180 μL ABTS+ solution. The reactive mixtures were kept in the dark for 5 min and subsequently measured the absorbance (B1) at 734 nm. The absorbance of the mixtures without test sample and ABST+ were set as B0 and B2, respectively. All experiments were executed in triplicate. The ABTS radical scavenging rate was calculated according to the following formula:

ABTS radical scavenging rate (%) = [B0-(B1-B2)]/B0 × 100%.

Ferric reducing antioxidant power assay (FRAP)

The ferric iron reducing activity was determined according the procedures by Kosakowska et al. [33]. 300 mM acetate buffer, 10 mM TPTZ (2,4,6-tris (2-pyridyl)-s-triazine) and 20 mM FeCl3 were mixed at a (v/v/v) ratio of 10:1:1 to prepared the working reagent. 100 μL of each test sample solution was mixed with 100 μL TPTZ working reagent, incubated at 37 °C for 20 min and the absorbance was determined at 593 nm. Meanwhile, a series of FeSO4 standard solutions in the concentration ranges of 0–1000 μg/mL were used to prepare the calibration curve. The ferric reducing capacity was calculated in the formation of an intense Fe2+-TPTZ blue complex. The results were expressed as Fe2+ antioxidant capacity (mmol FeSO4/g of extract).

Tyrosinase inhibitory activity

Tyrosinase inhibitory activities were determined by spectrophotometric method using L-DOPA as substrate [34]. Briefly, 50 μL sample solutions at different concentrations were mixed with 50 μL tyrosinase (200 units/mL, dissolved in pH 6.8 phosphate buffer) in 96-well plates and incubated for 15 min at 25 °C. The reaction was then initiated with the addition of L-DOPA (50 μL). After incubating of 30 min at 25 °C, the absorbance at 490 nm (Aa) was determined using a multiskan sky microplate spectrophotometer (Thermo Fisher Scientific, America). Similarly, the absorbance of the sample wells without tyrosinase (Ab) and the control wells with enzyme but without sample (Ab) were detected at the same time. The tyrosinase inhibitory activity was calculated by the equation as below:

Tyrosinase inhibitory rate (%) = [1− (Aa − Ab)/Ac] × 100%.

The IC50 was calculated using the GraphPad Prism® equation as below:

Y=min+max-min1+10x-logIC50×Hillslope

X represented the inhibitor concentration; Y represented the inhibition data (%) along with their minimal (min) and maximal (max) values; Hill slope is the slope factor.

Melanin inhibitory in zebrafish

Wild-type AB line zebrafish (provided by Hunter Biotechnology, Inc., Hangzhou, Zhejiang Province) were housed in fish water (0.2% instant ocean salt in deionized water, pH 6.9–7.2, conductivity 480–510 mS/cm, and hardness 53.7–71.6 mg/L CaCO3) in a 14/10 h light/dark photoperiod at a constant temperature 28 ± 0.5 °C, and fed live brine shrimp twice daily. The zebrafish embryos were obtained from natural spawning and collected within 30 min. The zebrafish assay was accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). The present study was approved by the IACUC (Institutional Animal Care and Use Committee) at Hunter Biotechnology, Inc. and the IACUC approval number was 001458.

Embryos at the 6 h post fertilization (hpf) stage were treated each extract at six concentrations (10, 30, 62.5, 125, 250 and 500 mg/L) for 72 h to evaluating the maximum non-lethal concentration (MNLC). As a result, the MNLCs of all the extract were more than 62.50 mg/L. 10 embryos were placed in 6-well and were exposed to tested samples at concentrations of 10 and 30 mg/L from 6 hpf to 54 hpf (48 h exposure). DMSO (0.05%, v/v) and arbutin (10 and 30 mg/L) were used as the normal and positive control, respectively.

Synchronized embryos were collected and observed under a stereomicroscope (SZX7, Olympus, Japan) equipped with a digital camera (VertA1, China). Melanin accumulation, directly correlated to the zebrafish pigmentation areas, was calculated using the GNU Image Manipulation Program (GIMP version 2.10.2) and expressed as percentage with respect to the negative control (melanin accumulation 100%) [28, 30].

Molecular docking study

158 compounds isolated from B. striata in the literature [2], including 19 glycosides, 28 bibenzyls, 19 phenanthrenes, 18 biphenanthrenes, 23 dihydrophenanthrenes, 5 anthocyanins, 11 steroids, 8 triterpenoids, 12 phenolic acids, 5 quinones, and 10 other compounds, were used as the ligands. The 3D structures were drawn by ChemBio3D and were optimized using MM2 and Autodock Tools. The 3D crystal structure of tyrosinase (PDB ID:5M8N) and adenylate cyclase (PDB ID:5IV3) were retrieved from RCSB Protein Data Bank (www.rcsb.org/pdb/home/home.do). All water molecules and hetero atoms were removed from the crystal structures by using Chimera and MGL Tools. Finally, Autodock Vina was used to dock the receptor protein with the small molecule ligands. Parameters of the receptor protein docking site were set as − 36.700, 7.034, − 19.104, and − 17.467, − 22.807, 2.786, respectively, according to the original ligand mimosine and LRE1 [35]. In order to achieve higher computational accuracy, 20 exhaustiveness parameters for each receptor were generated, and the conformation with the highest affinity was selected as the final docking conformation and visualized in Pymol 2.3. Meanwhile, the original ligands mimosine and LRE1 were taken as the positive control [36].

In silico ADMET prediction

The top 3 hits from B. striata possessed better binding affinity with tyrosinase and adenylate cyclase, were subjected to ADMET analysis. QikProp in Schrodinger suite was used to calculate their physical properties and drug-related characteristics, including molecular weight (MW), predicted octanol/water partition coefficient (QPlogPo/w), predicted aqueous solubility (QPlogS), predicted apparent Caco-2 cell permeability for gut-blood barrier (QPPCaco), predicted brain/blood partition coefficient (QPlogBB), predicted skin permeability (QPlogKp), predicted IC50 for blockage of HERG K+ channels (QPlog HERG) and predicted human oral absorption. The properties were assessed based on Lipinski’s rule of five and literature [37, 38].

Molecular dynamics simulation

In order to examine the stability and dynamic fluctuations of the ligand-protein complex under a simulated biological environment, and further validate the docking results, the compounds blestrin D (75) was chosen as the ligand for the molecular dynamics (MD) simulation study, based on the molecular docking result. The complex of blestrin D with tyrosinase and adenylate cyclase were performed MD simulations and run for 100 ns, using TIP3P water mode. The root mean square deviation (RMSD) values of protein backbone atoms relative to the initial structure were calculated to examine the protein stability over the course of simulation period [39].

Results

Chemical composition

The typical base peak chromatogram chromatograms of ETB and EFB were shown in Fig. 1. The PeakView™ software was used to identify the constituents. The molecular formula was accurately assigned within mass error of 10 ppm. The exact molecular weight and the fragment ions were used to identify the components according the literatures and the free chemical structure database, such as ChemSpider and Massbank. As a result, 39 chemical compositions, including 24 stilbenoids (bibenzyls, phenanthrenes and their derivatives), 6 glycosides, 4 phenolic acids, 3 quinones, 1 steroid, and 1 other compound were tentatively identified from EFB and ETB. At the same time, their relative semi-quantification was performed by measuring peak areas of each compound in MS mode using the extracted ion chromatograms [40]. The detailed information of the identification and their relative contents (heat map highlights, the darker the color, the higher the concentration) were summarized in Table 1.

Fig. 1.

Fig. 1

Base peak chromatogram of 95% ethanol extracts from B. striata tubers (A) and fibrous roots (B)

Table 1.

The compounds identified from the 95% ethanol extracts from B. striata tubers and fibrous roots by UPLC-Q-TOF-MS/MS, and their relative peak areas

NO. TR (min) Formula Found Mass [M + H]
(Da)
Error (ppm) Identification Relative peak areas (× 106)
ETB EFB
1 2.35 C13H18O7 285.0977 161.0450, 123.0444, 105.0352 −0.8 gastrodin 2.17 1.43
2 4.53 C7H6O3 137.0248 137.0244, 108.0224, 92.0275 3.1 p-hydroxybenzoic acid 0.77
3 6.70 C9H8O3 163.0406 145.8896, 119.0505, 93.0361 3.2 3-hydroxycinnamic acid 0.43
4 7.01 C34H32O8 567.2028 457.1678, 393.1388, 285.0978, 161.0454, 153.0573, 129.0579 0.6 bleochranol D 2.80
5 7.71 C40H56O22 887.3179 707.2520, 619.2221, 439.1590 −1.3 dactylorhin A 3.93 3.06
6 8.13 C21H22O8 401.1228 284.0313, 255.0290, 238.0630, 227.0337, 195.0465 −3.6 2,7-dihydroxy-4-methoxyphenanthrene-2-O-glucoside
7 8.21 C27H32O13 563.1747 540.6504, 429.8704, 394.1452, 320.7833, 310.8648 −4.1 2,7-dihydroxy-4-methoxyphenanthrene-2,7-O-diglucoside 1.18
8 9.62 C34H46O17 725.2635 457.1673, 285.0954, 171.0654, 153.0551, 123.0451 −3.8 militarine 30.48 38.39
9 9.76 C20H22O6 357.1332 313.0688, 225.0513, 181.0614, 121.0287, 77.0403 −3.3 pinoresinol
10 10.31 C21H26O8 405.1537 243.1015, 227.0705, 201.0893, 136.0531, 122.0400 −4.5 3′-hydroxy-5-methoxybibenzyl-3-O-β-D-glucopyranoside 0.72 1.56
11 11.08 C16H12O5 283.0601 237.0654, 211.0864, 75.0467 −3.8 1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione 1.53
12 12.15 C15H13O4 256.0734 239.0345, 211.0401, 201.8356, 167.0496, 143.0501 −3.0 7-hydroxy-2-methoxyphenanthrene-3,4-dione
13 12.42 C15H12O3 239.0714 224.0466, 196.0523, 167.0491 0.3 4-methoxyphenanthrene-2,7-diol 1.92
14 12.99 C16H14O4 269.0820 254.0563, 211.0388, 183.0448 0.2 2,7-dihydroxy-3,4-dimethoxyphenanthrene 6.01
15 13.54 C51H64O24 1059.3674 791.2752, 661.2301, 569.1989, 439.1569, 153.0557 −3.8 gymnoside X 1.07 0.89
16 13.64 C28H26O5 441.1691 347.1255, 253.0852, 241.0868, 211.0751, 93.0360 −3.7 shanciguol 1.51
17 13.80 C16H18O4 273.1126 243.1036, 227.0700, 185.0636, 136.0516, 122.0372, 106.0415 −2.2 3,3′-dihydroxy-5,4′-dimethoxybibenzyl
18 13.88 C15H16O3 243.1026 227.0707, 183.0810, 136.0537, 93.0357 −0.4 3,3′-dihydroxy-5-methoxybibenzyl 1.80
19 14.07 C22H20O4 347.1278 332.1024, 237.0561, 225.0549, 209.0622, 93.0352 −3.2 4,7-dihydroxy-1-(p-hydroxybenzyl)-2-methoxy-9,10-dihydrophenanthrene 0.32
20 14.26 C29H24O5 451.1507 437.1341, 392.1347, 329.0777, 224.0484 −9.8 1,8-bis(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol 8.73
21 14.31 C22H18O4 345.1124 330.0875, 302.0909, 237.0545 −2.4 1-(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol 0.25
22 14.50 C25H24O6 419.1480 405.1118, 377.1172, 225.0548 −4.8 bleochranol B 0.21 1.89
23 14.67 C23H20O5 375.1225 360.0979, 317.0802, 224.0484 −3.6 bleformin B 5.08
24 14.71 C30H26O6 481.1631 465.1301, 434.1102, 419.1264, 225.0548 −5.3 blestrin A 0.79 5.08
25 14.89 C22H22O4 349.1434 243.1017, 227.0704, 183.0810, 93.0356 −3.1 3,3′-dihydroxy-4-(p-hydroxybenzyl)-5-methoxybibenzyl
26 14.94 C30H24O6 479.1478 464.1236, 432.0980, 421.1041, 379.0948, 238.0631, 224.0478, 196.0533 −4.6 blestrin D 0.46 1.91
27 15.53 C32H26O8 537.1529 522.1312, 507.1027, 492.0773, 464.0849, 421.0668, 377.0799, 209.8293, 130.9680 −4.9 4,8,4′,8′-tetramethoxy-[1,1′-biphenanthrene]-2,7,2′,7′-tetrol 0.01 9.15
28 15.74 C37H32O7 587.2047 571.1716, 543.1831, 527.1544, 476.1243, 449.1367, 434.1257, 270.2400, 224.0534, 152.9984 −4.9 bleformin D 9.63
29 16.08 C15H14O3 241.0869 226.0615, 183.0449, 169.0667 −0.7 2,4-dimethoxyphenanthrene-7-ol 0.13 1.48
30 16.49 C27H26O7 461.1584 425.1723, 381.1463, 242.0897, 93.0338 −4.7 pleionesin C 0.04 0.36
31 16.61 C16H14O3 253.0862 238.0621, 223.0388, 195.0441, 167.0502 −3.1 2-hydroxy-4,7-dimethoxyphenanthrene 0.01 1.42
32 16.89 C18H18O4 297.1126 253.0491, 239.0346, 225.0942, 211.0392, 166.0456 −2.1 2,3,4,7-tetramethoxyphenanthrene 0.01 2.28
33 16.94 C29H26O5 453.1671 438.1428, 345.1106, 251.0712, 195.0470, 93.0362 −8.2 2,7-dihydroxy-1,6-bis(p-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene 0.10 0.64
34 17.46 C23H24O4 363.1585 333.1163, 255.0940, 227.0706, 199.0746, 157.0631, 93.0378 −4.7 bulbocol 0.15 3.85
35 17.67 C22H22O3 333.1486 163.1126, 107.0521, 75.0477 −3.2 5-hydroxy-2-(p-hydroxybenzyl)-3-methoxybibenzyl 0.60 3.34
36 18.27 C27H35O9 502.2211 369.2416, 337.2141, 193.1229, 163.1124, 147.0816, 133.1056 0.5 (20S,22R)-1β,2β,3β,4β,5β,7α-hexahydroxyspirost-25 (27)-en-6-one 9.14 1.06
37 18.30 C18H30O3 293.2117 275.1976, 249.1821, 235.1714, 221.1501, 171.1030, 121.1041, 59.0153 −1.7 striatolide 2.49
38 18.78 C16H32O2 255.2327 238.027, 224.0464, 210.0314, 195.0444, 182.0355, 167.0502 −1.0 palmitic acid 0.95
39 18.87 C31H23O8 522.1329 508.1470, 493.1272, 450.1078, 253.0495, 225.0527, 210.0426 1.7 3′,7′,7-trihydroxy-2,2′,4′-trimethoxy-[1,8′-biphenanthrene]-3,4-dione 7.20 0.76
Total 57.79 123.37

- means the relative peak areas is less than 0.01 × 106

Antioxidant capacity

It is well known that Ultraviolet A (UVA)-irradiation can induce reactive oxygen species (ROS) production and mediate excessive melanogenesis in skin cells. Natural polyphenol was the inhibitors of ROS generation and could be responsible for the anti-melanogenic activity of plant extracts [41, 42]. Thus, in the present study, the antioxidant capacity was assessed through DPPH, ABTS radical scavenging activity and FRAP assay. The results (Table 2 and Fig. 2) showed that the EFB (IC50 = 5.94 mg/L) possesses the strongest DPPH radical scavenging activity in vitro compared to the PTB (IC50 = 548.24 mg/L), PFB (IC50 = 285.81 mg/L), and ETB (IC50 = 65.25 mg/L). A similar trend was observed in ABTS and FRAP assay. The 95% ethanolic extracts of TB and PB had stronger antioxidation activity in vitro than their crude polysaccharides. In addition, EFB exhibit stronger antioxidation activity than ETB, which was consistent with the previous research results [25].

Table 2.

The results of antioxidant activity analyses in vitro (DPPH, ABTS and FRAP)

Sample IC50 values (mg/L) FRAP
mmol FeSO4/g
DPPH scavenging ABTS scavenging
PTB 548.24 ± 8.93a 626.49 ± 9.75a 0.11 ± 0.01a
PFB 285.81 ± 5.31b 348.62 ± 6.30b 0.42 ± 0.03b
ETB 65.25 ± 1.85c 78.40 ± 2.51c 2.45 ± 0.05c
EFB 5.94 ± 0.46d 11.69 ± 0.64d 6.92 ± 0.10d
Trolox 3.52 ± 0.27e 3.68 ± 0.31e

Within a row, different letters (a, b, c, d and e) indicate significant differences with p < 0.05

Fig. 2.

Fig. 2

The DPPH (A) and ABTS (B) radical scavenging activities of PTB, PFB, ETB, EFB, and Trolox

Tyrosinase inhibitory activity

Tyrosinase was the key rate-limiting enzyme in melanin biosynthesis pathway and was widely used to identify the potential of natural products with anti-melanogenesis effect [43]. The results (Fig. 3) showed that ETB and EPB had stronger tyrosinase inhibitory activity than PTB and PPB in vitro, which was consistent with previous research results [25]. EFB exhibited stronger tyrosinase inhibition activity in a dose dependent manner (between 20 and 200 mg/L) with IC50 = 58.92 mg/L than ETB (IC50 = 75.44 mg/L) and the positive compound arbutin (IC50 = 66.02 mg/L).

Fig. 3.

Fig. 3

Impact of melanogenic inhibitors on relative tyrosinase activity (A) in vitro and melanin synthesis (B) in zebrafish embryos

Melanin inhibitory in zebrafish

Zebrafish are recognized as a highly advantageous vertebrate model system to evaluate anti-melanogenesis activity, as it possesses similar organ systems and gene sequences to human beings [28]. Therefore, zebrafish was used to evaluate the anti-melanogenesis activity. As shown in Fig. 4, a large number of melanin (black spots) deposited in the zebrafish embryo in the control and 0.05% DMSO group. The microscopy images showed there was no significant difference in total melanin content between two groups (p > 0.05), indicating that the vehicle 0.05% DMSO didn’t affect the melanin production in zebrafish embryos. However, after exposure to the tested samples and arbutin for 48 h, zebrafish embryos exhibited varying degrees of melanin deposition (Figs. 3B, 4), excepting PFB 10 mg/L group. It is noticeable that the relative melanin contents in ETB 10 mg/L (78.38%) and 30 mg/L (64.72%) groups were significant lower than that in PTB 10 mg/L (93.06%) and 30 mg/L (82.02%) groups (p < 0.01). It demonstrated that the anti-melanogenesis activity of ETB was superior to that of PTB, which was consistent with the tyrosinase inhibitory activity. Whereafter, it is noteworthy that the anti-melanogenesis activities of ETB (81.65, 75.61%) and EFB (78.38, 64.72%) were stronger than that of arbutin (93.57, 81.48%) at the same dose of 10 mg/L and 30 mg/L (p < 0.01 or 0.05).

Fig. 4.

Fig. 4

The impacts of PTB, PFB, ETB and EFB on the melanin synthesis of zebrafish embryos (× 2 × 10 × 5.6)

Molecular docking

Tyrosinase is the rate-limiting enzyme in melanin biosynthesis: hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine (DOPA), and oxidation of DOPA to dopaquinone. Therefore, tyrosinase has been considered as a critical target for the development of melanogenesis inhibitors [44]. Additionally, adenylate cyclase is key enzyme of cAMP-induced melanogenesis. The binding of melanotropin alpha polypeptide (α-MSH) to MC1R receptors induced the activation of adenylate cyclase, increase in the cAMP level, up-regulated expression of tyrosinase gene, and subsequently increase the melanin synthesis [45]. Therefore, we performed a molecular docking study of the 158 compounds isolated from B. striata previously [2], with tyrosinase and adenylate cyclase. The binding energies of the studied ligands with tyrosinase and adenylate cyclase were summaried in Table S1. There were 83 (including 60 stilbenoids) and 85 (including 70 stilbenoids) compounds exhibit stronger binding affinities toward tyrosinase and adenylate cyclase, comparing to those of the original ligands mimosine (− 6.4 kcal/mol) and LRE1 (− 8.5 kcal/mol). 1,8-bis(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol (56), blestrin D (75), and 2,7-dihydroxy-1,6-bis(p-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene (93) were the top three ligands toward tyrosinase, with binding energy − 10.2, 10.0, and 9.7 kcal/mol, respectivey. While blestrin D (75), blestrin B (73), and 3,3′-dihydroxy-5-methoxy-2,5′,6-tris(p-hydroxybenzyl) bibenzyl (42) were the top three ligands toward adenylate cyclase, with binding energy − 12.1, − 11.9, and − 11.6 kcal/mol, respectivey. Their theoretical binding affinities and ligand-amino acid interactions were summaried in Table 3.

Table 3.

Summary of binding affinities and ligand-amino acid interactions

Protease Ligand Binding Energy (kcal/mol) H-Bond lipophilic
Tyrosinase 1,8-bis(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol −10.2 Lys233, Leu229, Arg114, Glu451, Arg230, Pro115, Gly107, Pro445, Met452, Tyr226, Ser106, Asn459
blestrin D −10.0 Arg114, Glu451 Pro446, Pro445, Ser106, Gly107, Cys113, Lys233, Arg230, Pro115, Tyr226, Leu229, Met452
2,7-dihydroxy-1,6-bis(p-hydroxybenzyl)-4-methoxy-9,10dihydrophenanthrene −9.7 Glu232, Gln236, Lys223, Cys113, Glu451, Ser106, Leu229, Ile128, Pro115, Tyr226, Val447, Gly107, Thr112
Adenylate cyclase blestrin D −12.1 Val167 Leu166, Lys95, Phe45, Ala97, Asn412, Arg416, Ala415, Val172, Phe336, Phe338, Arg176, Leu102, Met337
blestrin B −11.9 Met337, Val167 Met419, Phe338, Phe45, Lys95, Leu166, Phe165, Phe336, Leu102, Ala97, Phe296, Ala415, Arg416
3,3′,5-trimethoxybibenzyl −11.6 Asp47, Asn180 Ala100, Leu345, Ala97, Phe336, Phe296, Met419, Ala415, Met418, Lys95, Leu166, Val335, Phe165, Leu102, Phe45, Phe338, Arg176, Gln179

It was worth noting that blestrin D (75), a biphenanthrene compound, entered into the binding pocket of tyrosinase and adenylate cyclase (Fig. 5), and exhibited significant binding affinities toward both tyrosinase and adenylate cyclase. The Van der Walls interactions contributes to overall energy interaction value, meanwhile hydroxyl group produces hydrogen bonds with amino acid residues Glu 451, Arg114 of tyrosinase, and Val 167 of adenylate cyclase, respectivey (Table 3 and Fig. S1). Compound 93 also exhibited significant binding affinities toward tyrosinase through formation of 6 hydrogen bonds with amino acid residues Glu232, Glu451, Ser106, Cys113, Lys223, and Gln236.

Fig. 5.

Fig. 5

Best calculated poses for blestrin D inside binding pocket of homology model of tyrosinase (A) and adenylate cyclase (B)

In silico ADMET prediction

The predicted values of several important parameters along with their acceptable range were summarized in Table 4. Apart from the QPlogS of 3,3′,5-trimethoxybibenzyl, blestrin B and blestrin D, and QPlogBB of 3,3′,5-trimethoxybibenzyl, all the other calculated ADMET properties of the top three hits were within the expected ranges, meanwhile, the QPlog HERG of all the top three hits were less than − 5, indicating they were drugable potential for human use. The QPlog Kp of all the top three hits for both tyrosinase and adenylate cyclase, excepting 3,3′,5-trimethoxybibenzyl, were in the favorable range, indicating these compounds can easily penetrate into skin.

Table 4.

Qikprop calculated ADMET properties of the top three hits

Compounds MW QPlog
Po/w
QPlogS QPP
Caco
QP
logBB
QPlog
Kp
QPlog
HERG
Human oral absorption (%) Rule of five
3,3′,5-trimethoxybibenzyl 272.34 4.31 − 6.02 9906.04 − 0.15 − 0.15 −7.77 100.00 2
1,8-bis(p-hydroxybenzyl)-4-methoxyphenanthrene-2,7-diol 452.51 4.70 −6.25 149.72 −1.98 −2.81 −6.66 93.41 0
blestrin B 482.53 5.55 −7.26 661.17 −1.17 −2.10 −6.29 96.94 1
blestrin D 482.53 5.50 −7.47 452.82 −1.39 −2.43 −6.40 93.71 1
2,7-dihydroxy-1,6-bis(p-hydroxybenzyl)-4-methoxy-9,10dihydrophenanthrene 348.40 3.70 −4.91 375.43 −1.23 −2.73 −5.50 94.67 0

Recommended values: MW, 130.0–725.0; QPlogPo/w, −2 - 6.5; QPlogS, −6.5 - 0.5; QPPCaco < 25 is poor and > 500 is great; QPlogBB, −3 - 1.2; QPlogKp,–8.0 - –1.0; QPlog HERG, <− 5; human oral absorption (%) > 80% is high and < 25% is poor; rule of five, max 4

Molecular dynamic simulation

The RMSD plot showed that the RMSD values of the protein-ligand complex did not fluctuate significantly throughout the entire simulation period. The RMSD values (Fig. 6A) of blestrin D with tyrosinase and adenylate cyclase complex were determined ranging from 1.5 to 2.8 Å, and from 2.0 to 3.6 Å, respectively. The RMSF value reflecting the flexibility of each residue during simulations. The residues with higher RMSF values revealed they were more flexible (Fig. 6B). The RMSF values of the amino acid residues in loop regions were found to highly fluctuate. While, the active site residues kept a small RMSF value (less than 1.0 Å), such as Arg114, Val167, Tyr226, Leu229, and Arg230 in tyrosinase, and Val167, Leu102, Phe45, Lys95 and Leu166 in adenylate cyclase, indicating the binding pockets were kept stable. The molecular interactions of blestrin D with tyrosinase and adenylate cyclase were shown in Fig. 7.

Fig. 6.

Fig. 6

Dynamics of blestrin D bound to tyrosinase and adenylate cyclase. (A) The backbone RMSD of the protein along the simulation time. (B) RMSF for protein-inhibitor during MD simulation

Fig. 7.

Fig. 7

Molecular interactions of blestrin D with tyrosinase (A) and adenylate cyclase (B). Dashed lines represent the H-bonds

The binding free energies were calculated by molecular mechanics-generalized born surface area (MM-GBSA) method [39]. The predicted binding free energy of blestrin D with tyrosinase and adenylate cyclase were − 96.94 kcal/mol and − 139.69 kcal/mol, respectively, implying the binding interactions were spontaneous (Table 5). Furthermore, the contributions favoring ligand binding were nonpolar solvation interaction, van der Waals and electrostatic interaction.

Table 5.

Binding free energy (kcal/mol) of inhibitor-protein complexes along with the individual energy components (kcal/mol) contributions

Contribution Blestrin D-tyrosinase Blestrin D-adenylate cyclase
△GVDW −54.03 −72.34
△Gele −11.48 −28.68
△GGB 30.44 37.98
△GGA −61.71 −78.47
△Gbind −96.94 −139.69

△GVDW: The free energy of binding from the van der Waals energy, △Gele: The free energy of binding from the electrostatic energy, △GGB: The free energy of binding from the polar solvation energies, △GGA: The free energy of binding from the non-polar solvation, △Gbind: Free energy of binding

Discussion

It was worth noting that the types and contents of the chemical components in EFB were more than that in ETB. The peak areas of all the identified compounds in EFB were approximately two-fold of that in ETB. Militarine was the most abundant compounds in both EFB and ETB, which possessed significant antioxidant, anti-inflammatory and neuroprotection activities, and was chosen as the chemical markers for the quality control of B. striata in Chinese Pharmacopoeia 2020 edition [46]. The relative peak area of militarine in EFB (38.39 × 106) was slightly higher than that in ETB (30.48 × 106). Gastrodin is a well-known compound in many Chinese herbal medicines, such as Gastrodia elata, which exhibits significant tyrosinase inhibitory and radical scavenging effects [30]. The relative peak area of gastrodin in EFB (1.43 × 106) was slightly lower than that in ETB (2.17 × 106).

The 95% ethanolic extracts of TB and PB had stronger antioxidation activity in vitro than their crude polysaccharides. In addition, EFB exhibit stronger antioxidation activity than ETB, which was consistent with the previous research results [25]. This phenomenon may be attributed to that the EFB contains higher level of antioxidant compounds, such as militarine and stilbenoids (natural plant polyphenols). For example, the relative peak area of 4,8,4′,8′-tetramethoxy-[1,1′-biphenanthrene]-2,7,2′,7′-tetrol, a biphenanthrene with four phenolic hydroxyl groups, was 9.15 × 106 in FB, while it was 0.01 × 106 in TB.

In the present study, PPB and PTB showed slight tyrosinase inhibition activity in a dose dependent manner. However, it demonstrated that no activity was detected in the aqueous extract of PB (contains PPB) [25]. This phenomenon may be due to the different sample preparation. The aqueous extract of PB was used to the evaluate tyrosinase inhibitory activity in Jiang’s experiment [25], while in the present study, aqueous extract was precipitation with ethanol to obtain the crude polysaccharide.

Recently, the zebrafish model widely used in evaluation of anti-melanogenesis effect in vivo [47, 48]. Arbutin, a hydroquinone glucoside compound existing in various plants, which has been commercially used in the cosmetic industry, was set as positive control. The anti-melanogenesis activities of ETB and EFB were stronger than that of arbutin, indicating that ETB and EFB can be applied as skin-lightening agents in cosmetic industry.

The relative peak area of blestrin D in EFB (1.91 × 106), is approximately four times of that in ETB (0.46 × 106). The relative peak area of compound 56 (8.73 × 106) and 93 (0.64 × 106) in EFB is also significant higher than that in ETB (less than 0.01 × 106 and 0.10 × 106). This may be one of the reasons why EFB exhibits stronger anti-melanogenic effects than ETB. It is interesting to note that top three ligands toward tyrosinase and adenylate cyclase all belong to stilbenoids (bibenzyls, phenanthrenes and its derivative). Stilbenoids are the natural plant polyphenols, which has attracted great interest in the last years because of their remarkable bioactivities such as anti-inflammatory, antimicrobial and antioxidant activity [49]. Resveratrol is the most common stilbenoid. The previous research indicated that resveratrol and its derivatives can significantly inhibit the catalytic activity, gene expression, and posttranslational modifications of tyrosinase. Thus, they showed potentially useful as skin lightening and antiaging agents in cosmetics [41, 50].

Conclusions

In this study, the antioxidant and anti-melanogenic activity of the crude polysaccharide from the B. striata tuber (PTB) and fibrous roots (FPB), and 95% ethanol extract of B. striata tuber (ETB) and fibrous roots (EFB) were systematically investigated. The results showed that EFB possessed the strongest DPPH, ABTS radical scavenging activity and ferric iron reducing activity. In addition, ETB and EFB can significantly reduce tyrosinase activity in vitro and melanin synthesis of zebrafish embryos in a dose-dependent manner. Molecular docking indicated that there were a large number of compounds, mostly belonged to stilbenoids, exhibiting stronger binding affinities toward tyrosinase and adenylate cyclase, compared to the binding affinity of the original ligand. The present findings supported the rationale for the use of ETB and EFB as natural skin-whitening agents in pharmaceutical and cosmetic industries.

Supplementary Information

Additional file 1. (94.4KB, pdf)
Additional file 2. (311.5KB, pdf)

Acknowledgements

Hunter Biotechnology, Inc., Hangzhou, Zhejiang Province is highly acknowledged for performing the anti-melanogenic activity evaluation in zebrafish.

Abbreviations

TCM

Traditional Chinese medicine

TB

Bletilla striata tuber

FB

Bletilla striata fibrous roots

ETB

95% ethanol extract of Bletilla striata tuber

EFB

95% ethanol extract of Bletilla striata fibrous roots

PTB

Crude polysaccharide of Bletilla striata tuber

PFB

Crude polysaccharide of Bletilla striata fibrous roots

DPPH

2,2-Diphenyl-1-picrylhydrazyl

TPTZ

2,4,6-Tris (2-pyridyl)-s-triazine

FRAP

Ferric reducing antioxidant power assay

ABTS

2,2′-Azino-bis-(3-ethylbenthiazoline-6-sulphonic acid

Trolox

6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

L-DOPA

3-(3,4-Dihydroxyphenyl)-L-alanine

UPLC-Q-TOF-MS/MS

Ultra-high-performance liquid chromatography combined with quadrupole time-of-flight tandem mass spectrometry

MNLC

Maximum non-lethal concentration

ROS

Reactive oxygen species

MW

Molecular weight

QPlogPo/w

Predicted octanol/water partition coefficient

QPlogS

Predicted aqueous solubility

QPPCaco

Predicted apparent Caco-2 cell permeability for gut-blood barrier

QPlogBB

Predicted brain/blood partition coefficient

QPlogKp

Predicted skin permeability

QPlog HERG

Predicted IC50 for blockage of HERG K+ channels

MD

Molecular dynamics

RMSD

Random mean square deviation

MM-GBSA

Molecular mechanics-generalized born surface area

RMSF

Root mean square fluctuation

△GVDW

The free energy of binding from the van der Waals energy

△Gele

The free energy of binding from the electrostatic energy

△GGB

The free energy of binding from the polar solvation energies

△GGA

The free energy of binding from the non-polar solvation

△Gbind

Free energy of binding

Authors’ contributions

YYL, HJC designed the experiments, analyzed the data and drafted the manuscript; YYL performed the UPLC-Q-TOF-MS/MS analysis; SL, YW, ZRW performed the antioxidant analysis; JW, SJC performed the molecular docking analysis; All authors reviewed and approved the manuscript.

Funding

This work was supported by the Programs for Science and Technology Development of Quzhou (No.2018 k14), Zhejiang Traditional Chinese Medicine Technology Project (No.2020ZQ049), Ningbo Public Welfare Technology Project (2019C50064) and Zhejiang University Students’ Science and Technology Innovation Activity Plan (No.2021R460004).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

The study was carried out in compliance with the ARRIVE guidelines. All the methods were carried out in accordance with relevant guidelines and regulations. The study of melanin inhibitory in zebrafish was approved by the IACUC (Institutional Animal Care and Use Committee) at Hunter Biotechnology, Inc. and the IACUC approval number was 001458.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Zhang M, Shao Q, Xu E, Wang Z, Wang Z, Yin L. Bletilla striata: a review of seedling propagation and cultivation modes. Physiol Mol Biol Plants. 2019;25(3):601–609. doi: 10.1007/s12298-019-00644-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Xu D, Pan Y, Chen J. Chemical constituents, pharmacologic properties, and clinical applications of Bletilla striata. Front Pharmacol. 2019;10:1168. doi: 10.3389/fphar.2019.01168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.He X, Wang X, Fang J, Zhao Z, Huang L, Guo H, Zheng X. Bletilla striata: medicinal uses, phytochemistry and pharmacological activities. J Ethnopharmacol. 2017;195:20–38. doi: 10.1016/j.jep.2016.11.026. [DOI] [PubMed] [Google Scholar]
  • 4.Huang Y, Shi F, Wang L, Yang Y, Khan BM, Cheong KL, Liu Y. Preparation and evaluation of Bletilla striata polysaccharide/carboxymethyl chitosan/Carbomer 940 hydrogel for wound healing. Int J Biol Macromol. 2019;132:729–737. doi: 10.1016/j.ijbiomac.2019.03.157. [DOI] [PubMed] [Google Scholar]
  • 5.Zhang C, He Y, Chen Z, Shi J, Qu Y, Zhang J. Effect of polysaccharides from Bletilla striata on the healing of dermal wounds in mice. Evid Based Complement Alternat Med. 2019;2019:9212314. doi: 10.1155/2019/9212314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Morita H, Koyama K, Sugimoto Y, Kobayashi J. Antimitotic activity and reversal of breast cancer resistance protein-mediated drug resistance by stilbenoids from Bletilla striata. Bioorg Med Chem Lett. 2005;15(4):1051–1054. doi: 10.1016/j.bmcl.2004.12.026. [DOI] [PubMed] [Google Scholar]
  • 7.Zhang C, Gao F, Gan S, He Y, Chen Z, Liu X, Fu C, Qu Y, Zhang J. Chemical characterization and gastroprotective effect of an isolated polysaccharide fraction from Bletilla striata against ethanol-induced acute gastric ulcer. Food Chem Toxicol. 2019;131:110539. doi: 10.1016/j.fct.2019.05.047. [DOI] [PubMed] [Google Scholar]
  • 8.Wang W, Meng H. Cytotoxic, anti-inflammatory and hemostatic spirostane-steroidal saponins from the ethanol extract of the roots of Bletilla striata. Fitoterapia. 2015;101:12–18. doi: 10.1016/j.fitote.2014.11.005. [DOI] [PubMed] [Google Scholar]
  • 9.Jiang F, Li M, Wang H, Ding B, Zhang C, Ding Z, Yu X, Lv G. Coelonin, an anti-inflammation active component of Bletilla striata and its potential mechanism. Int J Mol Sci. 2019;20(18):4422. doi: 10.3390/ijms20184422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Song Y, Zeng R, Hu L, Maffucci KG, Ren X, Qu Y. In vivo wound healing and in vitro antioxidant activities of Bletilla striata phenolic extracts. Biomed Pharmacother. 2017;93:451–461. doi: 10.1016/j.biopha.2017.06.079. [DOI] [PubMed] [Google Scholar]
  • 11.Guo JJ, Dai BL, Chen NP, Jin LX, Jiang FS, Ding ZS, Qian CD. The anti-Staphylococcus aureus activity of the phenanthrene fraction from fibrous roots of Bletilla striata. BMC Complement Altern Med. 2016;16(1):491. doi: 10.1186/s12906-016-1488-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shi Y, Zhang B, Lu Y, Qian C, Feng Y, Fang L, Ding Z, Cheng D. Antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza a virus. BMC Complement Altern Med. 2017;17(1):273. doi: 10.1186/s12906-017-1780-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhang Y, Lv T, Li M, Xue T, Liu H, Zhang W, Ding X, Zhuang Z. Anti-aging effect of polysaccharide from Bletilla striata on nematode Caenorhabditis elegans. Pharmacogn Mag. 2015;11(43):449–454. doi: 10.4103/0973-1296.160447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chen Z, Zhao Y, Zhang M, Yang X, Yue P, Tang D, Wei X. Structural characterization and antioxidant activity of a new polysaccharide from Bletilla striata fibrous roots. Carbohydr Polym. 2020;227:115362. doi: 10.1016/j.carbpol.2019.115362. [DOI] [PubMed] [Google Scholar]
  • 15.Guan HY, Yan Y, Wang YL, Wang AM, Liu JH, He X, Li YJ, Huang Y, Liao SG. Isolation and characterization of two new 2-isobutylmalates from Bletilla striata. Chin J Nat Med. 2016;14(11):871–875. doi: 10.1016/S1875-5364(16)30104-2. [DOI] [PubMed] [Google Scholar]
  • 16.Jiang J, Chen HX, Tang XL, Zhou YF. Consideration on development of Bletillae striata based on whitening theory in traditional Chinese medicine. Chin Tradit Herbal Drugs. 2017;48(11):2313–2320. [Google Scholar]
  • 17.Zhang M, Han TT, Hu CF, Bai Y, Fan ZP, Hong L. Industrialization condition and sustainable development strategies of Bletillae Rhizoma. Chin Tradit Herbal Drugs. 2019;50(20):5103–5108. [Google Scholar]
  • 18.Chen MJ, Liu JY, Li FQ, Chen HP, Liu YP. Screening of effective parts of Bletilla striata inhibiting tyrosinase and scavenging DPPH free radical and its preparation technology. J Chengdu Univ Tradit Chin Med. 2017;40(2):15–19. [Google Scholar]
  • 19.Huang H, Peng L, Liu L, Xiao DA. Inhibition effect of Hyaeinth Bletilla extract on activity of tyrosinase. China Sur Det Cos. 2008;38(6):374–377. [Google Scholar]
  • 20.Lu XF. Study of rhizoma Bletillae striatae extracts in inducing apoptosis on mice melanoma B16 cells. Chin Arch Tradit Chin Med. 2013;31(7):1619–1621. [Google Scholar]
  • 21.Linghu L, Li CL, Yao XD. Effect of the aqueous extract of Bletilla striata on proliferation and migration of mouse melanoma B16F10 cells. J Zunyi Med Univ. 2018;41(4):408–412. [Google Scholar]
  • 22.Pillaiyar T, Manickam M, Namasivayam V. Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2017;32(1):403–425. doi: 10.1080/14756366.2016.1256882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gunia-Krzyzak A, Popiol J, Marona H. Melanogenesis inhibitors: strategies for searching for and evaluation of active compounds. Curr Med Chem. 2016;23(31):3548–3574. doi: 10.2174/0929867323666160627094938. [DOI] [PubMed] [Google Scholar]
  • 24.Chen JM, Yu XJ, Huang MP, Huang YF. Comparative studies of enzymatic assays and zebrafish system for evaluating whitening agents. J Anhui Univ. 2016;40(6):73–79. [Google Scholar]
  • 25.Jiang F, Li W, Huang Y, Chen Y, Jin B, Chen N, Ding Z, Ding X. Antioxidant, antityrosinase and antitumor activity comparison: the potential utilization of fibrous root part of Bletilla striata (Thunb.) Reichb.F. PLoS One. 2013;8(2):e58004. doi: 10.1371/journal.pone.0058004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yu HS, Dai BL, Qian CD, Ding ZS, Jiang FS, Jin B, Li MY. Antibacterial activity of chemical constituents isolated from fibrous roots of Bletilla striata. Chin Med Mat. 2016;39(3):544–547. [PubMed] [Google Scholar]
  • 27.Bouhajeb R, Selmi S, Nakbi A, Jlassi I, Montevecchi G, Flamini G, Zarrad I, Dabbou S. Chemical composition analysis, antioxidant, and antibacterial activities of eggplant leaves. Chem Biodivers. 2020;17(12):e2000405. doi: 10.1002/cbdv.202000405. [DOI] [PubMed] [Google Scholar]
  • 28.Choi TY, Kim JH, Ko DH, Kim CH, Hwang JS, Ahn S, Kim SY, Kim CD, Lee JH, Yoon TJ. Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res. 2007;20(2):120–127. doi: 10.1111/j.1600-0749.2007.00365.x. [DOI] [PubMed] [Google Scholar]
  • 29.Shi YP, Zhang YG, Li HN, Kong HT, Zhang SS, Zhang XM, Li XB, Liu KC, Han LW, Tian QP. Discovery and identification of antithrombotic chemical markers in Gardenia Fructus by herbal metabolomics and zebrafish model. J Ethnopharmacol. 2020;253:112679. doi: 10.1016/j.jep.2020.112679. [DOI] [PubMed] [Google Scholar]
  • 30.Veselinovic JB, Veselinovic AM, Ilic-Tomic T, Davis R, O'Connor K, Pavic A, Nikodinovic-Runic J. Potent anti-melanogenic activity and favorable toxicity profile of selected 4-phenylhydroxycoumarins in the zebrafish model and the computational molecular modeling studies. Bioorg Med Chem. 2017;25(24):6286–6296. doi: 10.1016/j.bmc.2017.09.021. [DOI] [PubMed] [Google Scholar]
  • 31.Chen ZY, Chen SH, Chen CH, Chou PY, Yang CC, Lin FH. Polysaccharide extracted from Bletilla striata promotes proliferation and migration of human tenocytes. Polymers (Basel) 2020;12(11):2567. doi: 10.3390/polym12112567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ali JS, Saleem H, Mannan A, Zengin G, Mahomoodally MF, Locatelli M, Abidin S, Ahemad N, Zia M. Metabolic fingerprinting, antioxidant characterization, and enzyme-inhibitory response of Monotheca buxifolia (Falc.) a. DC. Extracts. BMC Complement Med Ther. 2020;20(1):313. doi: 10.1186/s12906-020-03093-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kosakowska O, Baczek K, Przybyl JL, Pioro-Jabrucka E, Czupa W, Synowiec A, Gniewosz M, Costa R, Mondello L, Weglarz Z. Antioxidant and antibacterial activity of roseroot (Rhodiola rosea L.) dry extracts. Molecules. 2018;23(7):1767. doi: 10.3390/molecules23071767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Pandey BP, Pradhan SP, Adhikari K, Nepal S. Bergenia pacumbis from Nepal, an astonishing enzymes inhibitor. BMC Complement Med Ther. 2020;20(1):198. doi: 10.1186/s12906-020-02989-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Xia QD, Xun Y, Lu JL, Lu YC, Yang YY, Zhou P, Hu J, Li C, Wang SG. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19. Cell Prolif. 2020;53(12):e12949. doi: 10.1111/cpr.12949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wang J, Ge W, Peng X, Yuan LX, He SB, Fu XY. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis. Mol Divers. 2021. 10.1007/s11030-021-10244-0. [DOI] [PMC free article] [PubMed]
  • 37.Fu C, Shi H, Chen H, Zhang K, Wang M, Qiu F. Oral bioavailability comparison of artemisinin, deoxyartemisinin, and 10-deoxoartemisinin based on computer simulations and pharmacokinetics in rats. ACS Omega. 2021;6(1):889. doi: 10.1021/acsomega.0c05465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Uniyal A, Mahapatra MK, Tiwari V, Sandhir R, Kumar R. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. J Biomol Struct Dyn. 2020;23:1. doi: 10.1080/07391102.2020.1848636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Liu J, Zhou J, He F, Gao L, Wen Y, Gao L, Wang P, Kang D, Hu L. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening. Eur J Med Chem. 2020;192:112189. doi: 10.1016/j.ejmech.2020.112189. [DOI] [PubMed] [Google Scholar]
  • 40.Mahomoodally MF, Picot-Allain M, Zengin G, Llorent-Martinez EJ, Abdullah HH, Ak G, Senkardes I, Chiavaroli A, Menghini L, Recinella L, et al. Phytochemical analysis, network pharmacology and in silico investigations on Anacamptis pyramidalis tuber extracts. Molecules. 2020;25(10):2422. doi: 10.3390/molecules25102422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Boo YC. Human skin lightening efficacy of resveratrol and its analogs: from in vitro studies to cosmetic applications. Antioxidants (Basel) 2019;8(9):332. doi: 10.3390/antiox8090332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Jung SH, Kim J, Eum J, Choe JW, Kim HH, Kee Y, Lee K. Velutin, an aglycone extracted from Korean mistletoe, with improved inhibitory activity against melanin biosynthesis. Molecules. 2019;24(14):2549. doi: 10.3390/molecules24142549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kim DY, Won KJ, Hwang DI, Park SM, Kim B, Lee HM. Chemical composition, antioxidant and anti-melanogenic activities of essential oils from Chrysanthemum boreale Makino at different harvesting stages. Chem Biodivers. 2018;15(2):e1700506. doi: 10.1002/cbdv.201700506. [DOI] [PubMed] [Google Scholar]
  • 44.Kagotani K, Nakayama H, Zang L, Fujimoto Y, Hayashi A, Sono R, Nishimura N, Shimada Y. Lecithin-based dermal drug delivery for anti-pigmentation maize ceramide. Molecules. 2020;25(7):1595. doi: 10.3390/molecules25071595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ullah S, Park C, Ikram M, Kang D, Lee S, Yang J, Park Y, Yoon S, Chun P, Moon HR. Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues. Bioorg Chem. 2019;87:43–55. doi: 10.1016/j.bioorg.2019.03.001. [DOI] [PubMed] [Google Scholar]
  • 46.Li L, Hao B, Zhang Y, Ji S, Chou G. Metabolite profiling and distribution of militarine in rats using UPLC-Q-TOF-MS/MS. Molecules. 2020;25(5):1082. doi: 10.3390/molecules25051082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kim MK, Bang CY, Kim MY, Lee JH, Ro H, Choi MS, Kim DI, Jang YP, Choung SY. Traditional herbal prescription LASAP-C inhibits melanin synthesis in B16F10 melanoma cells and zebrafish. BMC Complement Altern Med. 2016;16:223. doi: 10.1186/s12906-016-1209-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Jeon HJ, Kim K, Kim C, Kim MJ, Kim TO, Lee SE. Molecular mechanisms of anti-melanogenic gedunin derived from neem tree (Azadirachta indica) using B16F10 mouse melanoma cells and early-stage zebrafish. Plants (Basel) 2021;10(2):330. doi: 10.3390/plants10020330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Seo JO, Yumnam S, Jeong KW, Kim SY. Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells. Arch Pharm Res. 2018;41(3):324–332. doi: 10.1007/s12272-018-1002-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mattio LM, Catinella G, Dallavalle S, Pinto A. Stilbenoids: a natural arsenal against bacterial pathogens. Antibiotics (Basel) 2020;9(6):336. doi: 10.3390/antibiotics9060336. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1. (94.4KB, pdf)
Additional file 2. (311.5KB, pdf)

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.


Articles from BMC Complementary Medicine and Therapies are provided here courtesy of BMC

RESOURCES